Eleni Christakou

机构：BerGenBio (Norway), University of Bergen · ORCID：0009-0006-4343-7431

发表论文 11 篇 · 总被引 165 次 · h-index 4

代表论文

• Phosphatidylserine receptors enhance SARS-CoV-2 infection (2021 · PLoS Pathogens · 被引 134)
• Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19 (2021 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 16)
• Structural characterization of two nanobodies targeting the ligand-binding pocket of human Arc (2024 · PLoS ONE · 被引 9)
• In vivo turnover and biodistribution of soluble AXL: implications for biomarker development (2024 · Scientific Reports · 被引 4)
• Structural Analysis of Tilvestamab in Complex with AXL (2025 · ACS Omega)
• Paratope mapping of tilvestamab, an anti-AXL function-blocking antibody, using high-throughput bacterial expression of secreted scFv-osmY fusion proteins (2025 · Bioscience Reports)